Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more. | Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

How specialty practices can get more out of technology investments

JD Power: Cost pressures worsen member experience with commercial plans

An insider’s look at LillyDirect

Pharma Industry News - Latest Updates & Insights

Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics are…

There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development

Biopharma sales trended upward in the first quarter of this year as eight of the industry’s top-25 companies achieved…

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,